Evidence map›Paper›PMID 24501674›Full record

ArticleInterface focus2014

Investigation of early cell-surface interactions of human mesenchymal stem cells on nanopatterned β-type titanium-niobium alloy surfaces.

Rebecca Medda, Arne Helth, Patrick Herre, Darius Pohl, Bernd Rellinghaus, Nadine Perschmann, Stefanie Neubauer, Horst Kessler, Steffen Oswald, Jürgen Eckert and 3 more

Abstract read
In one paragraph

Article in Interface focus, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Recent advances in engineering nanotopographic substrates for cell studies.Frontiers in bioengineering and biotechnology · 2022
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Rebecca MeddaInstitute for Physical Chemistry , Ruprecht-Karl-University of Heidelberg , Heidelberg 69120 , Germany ; Max Planck Institute for Intelligent Systems , Stuttgart 70569 , Germany.
Arne HelthInstitute for Complex Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Patrick HerreInstitute for Metallic Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Darius PohlInstitute for Metallic Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Bernd RellinghausInstitute for Metallic Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Nadine PerschmannInstitute for Physical Chemistry , Ruprecht-Karl-University of Heidelberg , Heidelberg 69120 , Germany ; Max Planck Institute for Intelligent Systems , Stuttgart 70569 , Germany.
Stefanie NeubauerInstitute for Advanced Study (IAS) and Center of Integrated Protein Science (CIPSM) , Technische Universität München , Lichtenbergstrasse 4, Garching 85747 , Germany.
Horst KesslerInstitute for Advanced Study (IAS) and Center of Integrated Protein Science (CIPSM) , Technische Universität München , Lichtenbergstrasse 4, Garching 85747 , Germany.
Steffen OswaldInstitute for Complex Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Jürgen EckertInstitute for Complex Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Joachim P SpatzInstitute for Physical Chemistry , Ruprecht-Karl-University of Heidelberg , Heidelberg 69120 , Germany ; Max Planck Institute for Intelligent Systems , Stuttgart 70569 , Germany.
Annett GebertInstitute for Complex Materials , IFW Dresden , PO Box 270116, Dresden 01171 , Germany.
Elisabetta A Cavalcanti-AdamInstitute for Physical Chemistry , Ruprecht-Karl-University of Heidelberg , Heidelberg 69120 , Germany ; Max Planck Institute for Intelligent Systems , Stuttgart 70569 , Germany.
Leibniz Institute for Solid State and Materials Research · DEMax Planck Institute for Intelligent Systems · DEMax Planck Society · DECenter for Integrated Protein Science Munich · DEInstitute for Advanced Study · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-potent adult mesenchymal stem cells (MSCs) derived from bone marrow have therapeutic potential for bone diseases and regenerative medicine. However, an intrinsic heterogeneity in their phenotype, which in turn results in various differentiation potentials, makes it difficult to predict the response of these cells. The aim of this study is to investigate initial cell-surface interactions of human MSCs on modified titanium alloys. Gold nanoparticles deposited on β-type Ti-40Nb alloys by block copolymer micelle nanolithography served as nanotopographical cues as well as specific binding sites for the immobilization of thiolated peptides present in several extracellular matrix proteins. MSC heterogeneity persists on polished and nanopatterned Ti-40Nb samples. However, cell heterogeneity and donor variability decreased upon functionalization of the gold nanoparticles with cyclic RGD peptides. In particular, the number of large cells significantly decreased after 24 h owing to the arrangement of cell anchorage sites, rather than peptide specificity. However, the size and number of integrin-mediated adhesion clusters increased in the presence of the integrin-binding peptide (cRGDfK) compared with the control peptide (cRADfK). These results suggest that the use of integrin ligands in defined patterns could improve MSC-material interactions, not only by regulating cell adhesion locally, but also by reducing population heterogeneity.

Indexed as

block copolymer micelle nanolithographycell adhesionhuman mesenchymal stem cellsnanopatterntitanium alloys

Identifiers

PMID24501674
PMCPMC3886311
OpenAlexW2098503692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.